Beloit Health System ophthalmologists are desperate to be some of the first in the area to use a new FDA medication now accepted to cure wet macular degeneration. Dr. Mario Rojas and Dr. Alice Townshend are arranging some of theirp atients for Eylea, the new medication that has been confirmed to decrease perspective decrease in wet age-related macular degeneration (AMD).
“The FDA has accepted the medication and is very safe with no more potential side effects than the past solutions. The research have been very effective,” describes Dr. Rojas. Beloit Clinic ophthalmologists. For more details, or to create an consultation, please contact 608-364-2204.
“The FDA has accepted the medication and is very safe with no more potential side effects than the past solutions. The research have been very effective,” describes Dr. Rojas. Beloit Clinic ophthalmologists. For more details, or to create an consultation, please contact 608-364-2204.
No comments:
Post a Comment